ArticleBlood advances2020

Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion.

Shaimaa S Eissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.